Companies House 2024-03-01 2025-02-28 false 07525101 2025-02-28 07525101 2024-03-01 2025-02-28 07525101 2023-03-01 2024-02-29 07525101 uk-bus:Director1 2024-03-01 2025-02-28 07525101 uk-bus:Director2 2024-03-01 2025-02-28 07525101 2024-03-01 2025-02-28 07525101 uk-bus:Micro-entities 2024-03-01 2025-02-28 07525101 uk-bus:FullAccounts 2024-03-01 2025-02-28 07525101 uk-bus:AuditExempt-NoAccountantsReport 2024-03-01 2025-02-28 07525101 2024-02-29 07525101 uk-core:WithinOneYear 2025-02-28 07525101 uk-core:WithinOneYear 2024-02-29 07525101 uk-core:AfterOneYear 2025-02-28 07525101 1 2024-03-01 2025-02-28 07525101 2 2024-03-01 2025-02-28 07525101 uk-core:AfterOneYear 2024-02-29 iso4217:GBP

Registered Number 07525101

HERBAL BIOTECH LIMITED

Micro-entity Accounts

28 February 2025

## HERBAL BIOTECH LIMITED Registered Number 07525101

## Micro-entity Balance Sheet as at 28 February 2025

| Notes | 2025 | 2024
--- | --- | --- | ---
|  | £ | £
Current Assets |  | 100 | 100
Net current assets (liabilities) |  | 100 | 100
Total assets less current liabilities |  | 100 | 100
Total net assets (liabilities) |  | 100 | 100
Capital and reserves |  | 100 | 100

- For the year ending 28 February 2025 the company was entitled to exemption under section 477 of the Companies Act 2006 relating to small companies.
- The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.
- The directors acknowledge their responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of accounts.
- The accounts have been prepared in accordance with the micro-entity provisions and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

Approved by the Board on 21 January 2026

And signed on their behalf by:
Peter Wilkinson, Director

## HERBAL BIOTECH LIMITED Registered Number 07525101

## Notes to the Micro-entity Accounts for the period ended 28 February 2025

1 Employees

| 2025 | 2024
--- | --- | ---
Average number of employees during the period | 0 | 0